Osmille D (Colecalciferol, Calcium Carbonate)

Colecalciferol, the active ingredient in Osmille D, is a vitamin D supplement presented as an oral dosage form for oral use. Together with calcium carbonate, it supports calcium absorption and is indicated for individuals with calcium or vitamin D deficiency and for the prevention of bone demineralisation.

GNH USA supplies Osmille D as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for global distribution.

Osmille D is used to address deficiencies in calcium and vitamin D, which are essential for bone health. - Calcium deficiency: helps restore normal calcium levels and supports bone mineralisation. - Vitamin D deficiency: increases serum 25‑hydroxyvitamin D concentrations, improving calcium absorption. - Osteoporosis prevention: provides essential nutrients to reduce bone loss in at‑risk populations.

Oral administration of Osmille D may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Constipation: reduced bowel movements. - Abdominal discomfort: cramps or bloating. - Hypercalcemia symptoms: mild fatigue or thirst.

Serious or Rare Side Effects: - Hypercalcemia: severe elevated calcium levels causing confusion or cardiac arrhythmia. - Kidney stones: formation due to excess calcium. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Hypervitaminosis D: toxicity presenting with vomiting, weakness, or renal impairment.

Before using Osmille D, consider the following precautions to ensure safe and effective therapy. - Assess calcium status: evaluate serum calcium levels in patients with known disorders. - Monitor renal function: patients with kidney disease may accumulate calcium. - Review medication list: avoid concurrent high‑dose calcium or vitamin D supplements without supervision. - Pregnancy and lactation: use only if prescribed after risk‑benefit assessment. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Osmille D can interact with certain medicines, altering calcium or vitamin D metabolism.

Major Interactions (Avoid): - Thiazide diuretics: may increase risk of hypercalcemia. - Vitamin D analogues (e.g., calcitriol): can cause excessive calcium levels. - Calcium‑containing antacids: may lead to calcium overload.

Moderate Interactions (Monitor Closely): - Corticosteroids: may reduce calcium absorption, requiring monitoring. - Anticonvulsants (e.g., phenytoin, phenobarbital): can accelerate vitamin D metabolism. - Bisphosphonates: concurrent use may affect bone turnover dynamics.